WB+淋巴细胞与抗体..ppt

  1. 1、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
WB+淋巴细胞与抗体..ppt

* * * * * * * * * * * * * * * * * * * * 新添加 * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * Somatic mutation in V genes During development of B cell, somatic mutations are occurring in the V gene, particularly in the place that codes for the second hypervariable region. Antibody mediated Immune Reactions -Opsonization 调理作用 -Neutralization 中和作用 -IgE and Hypersensitivity 超敏反应 -Antibody-dependent cell-mediated Cytotoxicity ADCC 抗体依赖细胞介导的细胞毒作用 Neutralization of Viruses Antibody-dependent cell-mediated cytotoxicity (ADCC) Opsonization Production of IgE FceR1 Mast cell activation Release of mediators mediators Response of target organs Blood vessels Vascular leakage Bronchi Constriction Intestines Hypermotility IgE and immediate hypersensitivity B mast cell Target cell Killer cell Antibodies – Nature’s pro-drugs Antibody Fc receptor Complement Hybridomas and Monoclonal Antibody 杂交瘤和单克隆抗体 (Georges Kohler and Cesar Milstein, 1975) + Selection in HAT medium Fusion Myeloma B cell Immunization with Antigen A Selection for specific clone Antigen A specific Monoclonal antibody (Hypoxanthine and Thymidine) 抗原表位 1984 Nobel Prize Niels K. Jerne, Georges J. F. Kohler and Cesar Milstein. Genetic engineering antibody Chimeric antibody Humanized antibody Single chain antibody Bispecific antibody Mouse Ab From Mouse Human Ab From Human Chimeric Ab Humanized Ab Mouse Ab Human Ab Single chain antibody Shark VL Camel VH VL Human scFv VH Shark domain antibody (12 kDa) scFv Diabody Triabody Valency Neutralisation Type Application Targets Mode Infliximab Rheumatoid arthritis , Crohns disease, Ulcerative Colitis TNF-α chimeric Basiliximab Acute rejection of kidney transplants IL-2 on activated T cells chimeric Bevacizumab Anti-angiogenic cancer therapy VEGF humanized Abciximab Prevent coagulation in coronary angioplasty receptor GpIIb/IIIa on platelets chimeric Daclizumab Acute rejection of kidney transplants IL-2 on activated T cells humanized Gemtuzumab

文档评论(0)

文档资料 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档